Colucid Pharma Cmn (CLCD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CLCD | AZN | AMGN | GILD | BMY |
| Company | Colucid Pharma Cmn | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 46.50 | 188.14 | 348.01 | 140.43 | 58.26 |
| High | 46.55 | 188.40 | 351.25 | 141.00 | 58.55 |
| Low | 46.45 | 184.97 | 346.51 | 137.93 | 56.98 |
| Latest | 46.53 | 185.56 | 348.41 | 137.70 | 57.29 |
| Change | +0.03 | -3.37 | -1.51 | -3.41 | -0.82 |
| % Change | +0.06% | -1.78% | -0.43% | -2.42% | -1.41% |
| Volume | 127,000 | 1,041,263 | 1,630,199 | 2,930,890 | 4,545,401 |
| 20-Day Average Volume | 245,780 | 1,807,551 | 2,432,569 | 6,206,279 | 12,106,994 |
| Previous Close | 46.50 | 188.93 | 349.92 | 141.11 | 58.11 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 46.44 | 197.04 | 371.73 | 145.73 | 60.39 |
| 20-Day Raw Stochastic | 70.00% | 3.71% | 4.44% | 3.06% | 9.14% |
| 20-Day Relative Strength | 67.22 | 40.47 | 42.03 | 43.88 | 44.58 |
| Weighted Alpha | +162.70 | +25.35 | +14.74 | +31.09 | +4.95 |
| Today's Opinion | N/A | 40% Buy | 56% Buy | 56% Buy | 56% Buy |
| Previous Opinion | N/A | 56% Buy | 56% Buy | 64% Buy | 56% Buy |
| Last Month's Opinion | N/A | 100% Buy | 100% Buy | 100% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.06% since 02/21/17 | -2.11% since 03/13/26 | -4.84% since 03/13/26 | -4.36% since 03/13/26 | -2.56% since 03/13/26 |
| Low | 46.45 on 02/28/17 | 184.98 on 03/20/26 | 346.51 on 03/20/26 | 138.23 on 03/20/26 | 57.03 on 03/20/26 |
| High | 46.55 on 02/28/17 | 193.96 on 03/17/26 | 370.89 on 03/16/26 | 146.71 on 03/17/26 | 60.81 on 03/17/26 |
| 1-Month | |||||
| %Chg | +0.61% since 01/27/17 | -8.96% since 02/20/26 | -7.00% since 02/20/26 | -8.41% since 02/20/26 | -5.10% since 02/20/26 |
| Low | 46.20 on 01/30/17 | 184.98 on 03/20/26 | 346.51 on 03/20/26 | 138.23 on 03/20/26 | 57.03 on 03/20/26 |
| High | 46.65 on 02/08/17 | 209.93 on 02/27/26 | 391.29 on 03/02/26 | 152.46 on 02/23/26 | 62.89 on 03/02/26 |
| 3-Month | |||||
| %Chg | +37.26% since 11/28/16 | +1.74% since 12/19/25 | +6.45% since 12/19/25 | +11.57% since 12/19/25 | +6.23% since 12/19/25 |
| Low | 31.25 on 01/06/17 | 178.08 on 01/21/26 | 318.21 on 01/05/26 | 116.88 on 01/05/26 | 52.06 on 01/05/26 |
| High | 46.65 on 02/08/17 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| 6-Month | |||||
| %Chg | +441.05% since 08/26/16 | +21.85% since 09/19/25 | +22.11% since 09/19/25 | +21.54% since 09/19/25 | +27.87% since 09/19/25 |
| Low | 8.65 on 08/29/16 | 145.79 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 42.52 on 10/29/25 |
| High | 46.65 on 02/08/17 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 897,098 | 293,013,024 | 188,630,688 | 175,176,928 | 118,339,512 |
| Shares Outstanding, K | 19,280 | 1,550,908 | 539,068 | 1,241,421 | 2,036,474 |
| Annual Sales | 0 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | -30,740,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | N/A | 15,503,000,000 | 9,866,000,000 | 7,925,000,000 | 12,502,000,000 |
| Last Quarter Net Income | N/A | 2,321,000,000 | 1,333,000,000 | 2,183,000,000 | 1,086,000,000 |
| 60-Month Beta | 1.51 | 0.32 | 0.45 | 0.37 | 0.26 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 2.12 on 02/10/26 | 5.29 on 02/03/26 | 1.86 on 02/10/26 | 1.26 on 02/05/26 |
| Latest Earnings Date | 03/01/17 | 05/05/26 | 05/07/26 | 04/23/26 | 04/23/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.820 on 03/13/26 | 0.630 on 01/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 03/13/26 | 04/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 20.57 | 16.09 | 17.34 | 9.65 |